Veeva Systems has enhanced its AI capabilities in the life sciences sector with the acquisition of Copli, a leader in medical, legal, and regulatory (MLR) solutions. This strategic move is complemented by the launch of Veeva Falcon MLR, an AI-driven tool designed to expedite content review and approval processes.
This acquisition not only broadens Veeva's AI portfolio but also strengthens its Commercial Cloud offerings, likely boosting customer adoption and creating new cross-selling opportunities. The Falcon MLR is expected to significantly reduce manual labor in MLR tasks, potentially eliminating over 70% of such work within five years, thereby improving operational efficiency for pharmaceutical and biotechnology firms.
As the demand for faster content approvals in compliance-heavy environments grows, Falcon MLR's integration with existing tools like Veeva PromoMats is poised to enhance customer retention and reinforce Veeva's competitive edge in the life sciences software market. The initiative aligns with a broader trend in the industry towards automation and AI integration, which is projected to see substantial growth in the coming years.
This acquisition positions Veeva favorably within a rapidly evolving market, where the global agentic AI in healthcare is expected to expand from approximately $538 million in 2024 to nearly $5 billion by 2030. Veeva's proactive approach to embedding AI in its offerings indicates a strong commitment to meeting the needs of an increasingly digital and efficiency-driven healthcare landscape.